GREENWICH, Conn.--(BUSINESS WIRE)--Aptuit, Inc. announced today that it will invest an additional $100 million in capital projects to expand capacity, improve operating efficiency, and further align its global operations. This announcement comes on the heels of the completion of two major acquisitions, SSCI and EaglePicher Pharmaceutical Services, adding world-class physical chemistry and active pharmaceutical ingredient development and manufacturing to Aptuit’s already comprehensive service capabilities. The internal investment marks Aptuit’s commitment to maintaining exceptional operational quality, delivering increasingly global customer projects on time, seamlessly and to exact specifications.
